- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Contacts
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2020 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
PhRMA Perspectives on Drug Substance Regulatory Filing Issues
February 2, 2003
Source: Pharmaceutical Technology
Issue 2,Volume 27
The PhRMA API Technical Group examines topics concerning active pharmaceutical ingredient development and manufacture and makes recommendations for regulatory guidance.